341, 349, n.4 (2001) (The FDCA leaves no doubt that it is the Federal Government rather than private litigants who are authorized to file suit for noncompliance with the medical device provisions)
Any promotional activity, including so-called awareness campaigns, that functions as a surrogate advertisement for prescription-only drugs shall be viewed seriously and may be treated as irrational or misleading marketing practice, stated Dr Rajeev Singh Raghuvanshi, Drugs Controller General of India
Brain health deserves better than a buzzword
If youre struggling with weight management despite diet and exercise efforts, our doctors at a medical aesthetic clinic in Singapore can evaluate your suitability for weight loss injections and develop a personalised treatment plan
Healthcare providers usually recommend gradual dose escalation to minimize gastrointestinal symptoms
Some laboratory studies have shown that GLP-1 analogs may reduce cartilage degradation and synovial inflammation in experimental arthritis models